BEACOPP-14 VS BEACOPP-ESC IN PATIENTS WITH HODGKIN'S LYMPHOMA FROM POOR-PROGNOSIS GROUP: PRELIMINARY RESULTS OF PROSPECTIVE RANDOMIZED MULTYCENTER STUDY

被引：0
|
作者：
Kriachok, I. [1 ]
Titorenko, I. [1 ]
Filonenko, K. [1 ]
Aleksik, E. [1 ]
Novosad, O. [1 ]
Kadnikova, T. [1 ]
Kushchevoy, E. [1 ]
Martinchik, A. [1 ]
Pastushenko, Y. [1 ]
机构：
[1] Natl Canc Inst, Kiev, Ukraine
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1366
引用
收藏
页码：550 / 550
页数：1
相关论文
共 50 条
  • [31] ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial
    Federico, Massimo
    Luminari, Stefano
    Iannitto, Emilio
    Polimeno, Giuseppe
    Marcheselli, Luigi
    Montanini, Antonella
    La Sala, Antonio
    Merli, Francesco
    Stelitano, Caterina
    Pozzi, Samantha
    Scalone, Renato
    Di Renzo, Nicola
    Musto, Pellegrino
    Baldini, Luca
    Cervetti, Giulia
    Angrilli, Francesco
    Mazza, Patrizio
    Brugiatelli, Maura
    Gobbi, Paolo G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 805 - 811
  • [32] Fertility in male patients with Hodgkin's disease after therapy - results from the German Hodgkin Lymphoma Study Group (GHSG).
    Sieniawski, M
    Josting, A
    Breuer, K
    Sven, T
    Diehl, V
    Engert, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 569S - 569S
  • [33] Male fertility in patients with Hodgkin's disease after therapy results from the German Hodgkin Lymphoma Study Group (GHSG).
    Sieniawski, M
    Josting, A
    Breuer, K
    Diehl, V
    Engert, A
    BLOOD, 2003, 102 (11) : 501A - 502A
  • [34] Bi-weekly dosing preserves the efficacy of rituximab in elderly patients with poor-prognosis DLBCL: Results from the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study group (DSHNHL).
    Schubert, J.
    Reiser, M.
    Wenger, M.
    Kloess, M.
    Lengfelder, E.
    Franke, A.
    Steinhauer, H. B.
    Clemens, M.
    Schmitz, N.
    Loeffler, M.
    Pfreundschuh, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 431S - 431S
  • [35] Dose-dense rituximab improves outcome of elderly patients with poor-prognosis Diffuse Large B-cell Lymphoma (DLBCL): Results of the DENSE-R-CHOP-14 trial of the german high-grade non-hodgkin lymphoma study group (DSHNHL)
    Pfreundschuh, M.
    Zeynalova, S.
    Poeschel, V.
    Haenel, M.
    Schmitz, N.
    Hensel, M.
    Reiser, M.
    Loeffler, M.
    Schubert, J.
    ONKOLOGIE, 2008, 31 : 118 - +
  • [36] Dose-dense rituximab improves outcome of elderly patients with poor-prognosis diffuse large B-cell lymphoma (DLBCL): Results of the DENSE-R-CHOP-14 trial of the German high-grade non-Hodgkin lymphoma study group (DSHNHL)
    Pfreundschuh, Michael
    Zeynalova, Samira
    Poeschel, Viola
    Haenel, Mathias
    Schmitz, Norbert
    Hensel, Manfred
    Reiser, Marcel
    Loeffler, Markus
    Schubert, Joerg
    BLOOD, 2007, 110 (11) : 243A - 243A
  • [37] The clinical utility of the Revised European-American Lymphoma (REAL) Classification: Preliminary results of a prospective study in patients with non-Hodgkin's lymphoma from a single centre
    Sweetenham, JW
    Smartt, PFM
    Wilkins, BS
    Pellatt, JC
    Smith, JL
    Ramsay, A
    Whitehouse, JMA
    ANNALS OF ONCOLOGY, 1999, 10 (09) : 1121 - 1124
  • [38] No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group
    Behringer, K.
    Wildt, L.
    Mueller, H.
    Mattle, V.
    Ganitis, P.
    van den Hoonaard, B.
    Ott, H. W.
    Hofer, S.
    Pluetschow, A.
    Diehl, V.
    Engert, A.
    Borchmann, P.
    ANNALS OF ONCOLOGY, 2010, 21 (10) : 2052 - 2060
  • [39] Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination of gemcitabine and bleomycin:: A report of the German Hodgkin's lymphoma Study Group
    Bredenfeld, H
    Franklin, J
    Nogova, L
    Jesting, A
    Fries, S
    Mailänder, V
    Oertel, J
    Diehl, V
    Engert, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2424 - 2429
  • [40] Improved outcome of elderly patients with poor-prognosis diffuse large B-cell lymphoma (DLBCL) after dose-dense rituximab:: Results of the DENSE-R-CHOP-14 trial of the German high-grade non-Hodgkin lymphoma study group (DSHNHL)
    Pfreundschuh, M.
    Zeynalova, S.
    Poeschel, V.
    Haenel, M.
    Schmitz, N.
    Ho, A. D.
    Reiser, M.
    Loeffler, M.
    Schubert, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 99 - 100
12345